A novel erythropoiesis-stimulating agent (AMG114) with 131-hour half-life effectively treats chemotherapy-induced anemia when administered as 200 mcg every 3 weeks No significant financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results